| 标题 |
Prexasertib, a cell cycle checkpoint kinase 1 and 2 inhibitor, in BRCA wild-type recurrent high-grade serous ovarian cancer: a first in class, proof-of-concept, single arm phase 2 study |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet Oncology 作者:Jung-Min Lee; J. Nair; A. Zimmer; S. Lipkowitz; C. Annunziata; et al 出版日期:2018-01-18 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)